Protalix (PLX) Discloses $30M Pfizer Taliglucerase Alfa Supply Agreement In Latin American
Tweet Send to a Friend
In an 8-K filing today from Protalix BioTherapeutics, Inc. (NYSE: PLX), the company announced that on August 10, 2010, Pfizer ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
